International stocks trading in New York close higher
- ADRs end higher with S&P/BNY Mellon index gaining 0.3%
- Amarin climbs 33%, Aslan Pharmaceuticals soars 25%, Zepp Health gains 24%
- Akso Health Group declines 22%, Addex Therapeutics tumbles 20%, Renalytix drops 15%
International stocks trading in New York closed higher on Wednesday, with the S&P/BNY Mellon index of American depositary receipts gaining 0.3%. The top performers during the session were Amarin, which climbed 33%, Aslan Pharmaceuticals, which soared 25%, and Zepp Health, which gained 24%. On the other hand, Akso Health Group declined 22%, Addex Therapeutics tumbled 20%, and Renalytix dropped 15%.
Public Companies: Amarin (Unknown), Aslan Pharmaceuticals (Unknown), Zepp Health (Unknown), Akso Health Group (Unknown), Addex Therapeutics (Unknown), Renalytix (Unknown)
Private Companies:
Key People:
Factuality Level: 8
Justification: The article provides factual information about the performance of international stocks trading in New York. The data source is mentioned, which adds credibility to the information provided.
Noise Level: 2
Justification: The article is primarily focused on providing information about the performance of international stocks trading in New York. It does not contain any irrelevant or misleading information, and it stays on topic without diving into unrelated territories. However, it lacks thoughtful analysis, scientific rigor, and actionable insights. It simply reports the gains and losses of various stocks without providing any context or explanation.
Financial Relevance: Yes
Financial Markets Impacted: International stocks trading in New York
Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The article provides information on the performance of international stocks trading in New York, indicating financial relevance.
www.marketwatch.com 
